Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001201935-12-000060
Filing Date
2012-10-04
Accepted
2012-10-04 10:54:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 424b3letter.txt 424B3 1694
2 EXHIBITA.txt EX-1 47721
  Complete submission text file 0001201935-12-000060.txt   50399
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 424B3 | Act: 33 | File No.: 333-147677 | Film No.: 121128717
SIC: 2834 Pharmaceutical Preparations